Liver diseases

Latest research

1. Semaglutide

   in Reactions Weekly

   Article 18 October 2025

2. Tremelimumab/Durvalumab

   in Reactions Weekly

   Article 18 October 2025

3. Human genetics of steatotic liver disease: insights into insulin resistance and lipid metabolism

   • Rosellina M. Mancina
   • Luca Valenti
   • Stefano Romeo

   in Nature Metabolism

   Article 17 October 2025

   

4. The efficacy and safety analysis of D-TACE combined with donafenib and tislelizumab in recurrent hepatocellular carcinoma after surgery

   • Haohao Lu
   • Bin Liang
   • Chuansheng Zheng

   in Scientific Reports

   Article Open access 17 October 2025

   

5. Orchestration of hepatocyte inflammatory responses by monocytes during acute viral hepatitis in ducks in vitro

   • Lizhen Gong
   • Xiaoming Lin
   • Xumin Ou

   in Veterinary Research

   Article Open access 17 October 2025

   

6. Pyogenic liver abscess in the North Denmark Region - a population-based cohort study (2010–2022)

   • Margarita Dudina
   • Søren Schou Olesen
   • Hans Linde Nielsen

   in European Journal of Clinical Microbiology & Infectious Diseases

   Article Open access 17 October 2025

   

7. Incidence and outcomes of extubation failure in mechanically ventilated patients with cirrhosis: a post-hoc analysis of a prospective multicenter study

   • Yassir Aarab
   • Joris Pensier
   • Samir Jaber

   in Annals of Intensive Care

   Article Open access 16 October 2025

   

8. OFT-DNN-EATLSS: An Enhanced Deep Learning-Based Approach for Efficient Cirrhosis Liver Disease Classification and Segmentation Using Multimodality Images

   • G. Sai Chaitanya Kumar
   • Narendhar Mulugu
   • G. N. Beena Bethel

   in Biomedical Materials & Devices

   Article 15 October 2025

   

9. Evaluation of the Modifying impact of myrtenol on intrahepatic cholestasis and extrahepatic cholestasis in male rats: role of oxidative stress and inflammation

   • Mohammad Amin Rajizadeh
   • Masoumeh Ghasemi
   • Sedigheh Amiresmaili

   in Advances in Traditional Medicine

   Article 15 October 2025

   

10. Area Deprivation Index as a Predictor of Hepatocellular Carcinoma Prognosis: Limited Predictive Utility in an Integrated Care Model

    • Avi Toiv
    • Hope B O’Brien
    • Reena J Salgia

    in Journal of Gastrointestinal Cancer

    Article 15 October 2025

    

11. Taming fatty liver: can taurine combat metabolic dysfunction in MASLD?

    • Lin Meng
    • Fayu Lu
    • Jian Gao

    in Cell Communication and Signaling

    Article Open access 15 October 2025

    

12. Preclinical and clinical evidence of xanthine oxidase inhibitors in metabolic dysfunction-associated steatotic liver disease: a systematic review and meta-analysis

    • Steven Alvianto
    • Yovita Gotama
    • Mario Stefanus

    in Egyptian Liver Journal

    Article Open access 15 October 2025

    

13. Variation by age, smoking, and menopausal status in the impact of body mass index change on liver cancer risk

    • Su Youn Nam
    • Junwoo Jo
    • Chang-Min Cho

    in Scientific Reports

    Article Open access 15 October 2025

    

14. Afwijkende leverfuncties

    • Jolanda Timmermans

    in Nursing

    Article 14 October 2025

    

15. Prevalence, demographic characteristics and clinical profile of metabolic dysfunction-associated fatty liver disease among adult patients attending tertiary hospitals in Dodoma, Tanzania. a cross-sectional study

    • Francis Msagati
    • Baraka Alphonce
    • Emmanuel Sindato

    in BMC Gastroenterology

    Article Open access 14 October 2025

    

16. Associations between circulating amino acids and hepatic steatosis indices in Iranian adults aged over 50: findings from the Bushehr elderly health (BEH) program

    • Azadeh Zarinkolah
    • Neda Cheraghloo
    • Bagher Larijani

    in Journal of Diabetes & Metabolic Disorders

    Article 14 October 2025

    

17. Machine learning predicts post-transplant muscle loss in hepatocellular carcinoma patients without sarcopenia

    • Jinyan Chen
    • Zhihang Hu
    • Di Lu

    in BMC Cancer

    Article Open access 14 October 2025

    

18. The Emerging Therapeutic Promise of SGLT2 Inhibitors in Metabolic Dysfunction-Associated Steatotic Liver Disease

    • Wenjing Zhang
    • Huaidong Hu

    in Digestive Diseases and Sciences

    Article 14 October 2025

    

19. Metabolic dysfunction–associated steatotic liver disease in individuals with type 2 diabetes mellitus and diabetic foot ulcers: prevalence and associated factors

    • Hüseyin Karaaslan
    • Ensar Gazi Göçer
    • Ferit Doğan

    in Journal of Diabetes & Metabolic Disorders

    Article 14 October 2025

20. Beyond hepatitis: the growing burden of alcohol and MASLD in liver cancer mortality

    • Sheilabi Seeburun
    • Priyaranjan Kata
    • Jose Iglesias

    in The Egyptian Journal of Internal Medicine

    Article Open access 14 October 2025